Clinical Research Directory
Browse clinical research sites, groups, and studies.
NVTIA® Ergothioneine for Healthy Aging and Skin Health
Sponsor: EUROPEAN LIFE SCIENCE RESEARCH ASSOCIATION
Summary
This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effects of NVTIA® Ergothioneine, a branded ergothioneine ingredient, on healthy aging biomarkers and skin health in healthy adults aged 40 to 65 years. Participants will receive either NVTIA® Ergothioneine or a matching placebo once daily for 12 weeks. The primary objective of this study is to evaluate the effects of NVTIA® Ergothioneine supplementation on biomarkers associated with oxidative stress and healthy aging. Secondary objectives include assessment of skin elasticity, skin hydration, inflammatory biomarkers, and overall safety. The findings of this study are expected to provide clinical evidence supporting the role of NVTIA® Ergothioneine in promoting healthy aging and maintaining skin health.
Official title: A Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effects of NVTIA® Ergothioneine Supplementation on Healthy Aging Biomarkers and Skin Health in Healthy Adults
Key Details
Gender
All
Age Range
35 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2026-08-15
Completion Date
2027-04-08
Last Updated
2026-08-06
Healthy Volunteers
Yes
Conditions
Interventions
NVTIA® Ergothioneine
NVTIA® Ergothioneine is a standardized branded ergothioneine ingredient manufactured under controlled quality standards for use as a dietary supplement.
Placebo
Matching placebo capsules identical in appearance, color, size, and packaging to the investigational product. One capsule will be administered orally once daily for 12 weeks.
Locations (1)
Dhaka Central International Medical College & Hospital
Dhaka, Bangladesh